SCNP (Scandinavian College of Neuropsychopharmacology) is the leading psychopharmacology organisation in the Nordic countries, Sweden, Norway, Denmark, Iceland and Finland.
Its mission is to promote research and education in neuropsychopharmacology. It also provides advice on all aspects of neuro-psychiatric drugs. Through these activities it seeks to advance research thus leading to improved patient care.
The SCNP journal, ‘Acta Neuropsychiatrica’ is becoming an essential journal and grows in importance.
SCNP welcomes membership applications from all who are dedicated to the highest quality research in neuropsychopharmacology.
Submit your research to Acta Neuropsychiatrica
Acta Neuropsychiatrica, the official Journal of Scandinavian College of Neuropsychopharmacology, is an international journal focussing on translational neuropsychiatry. It publishes high-quality original research papers and reviews. The Journal’s scope specifically highlights the pathway from discovery to clinical applications, healthcare and global health that can be viewed broadly as the spectrum of work that marks the pathway from discovery to global health. The steps of translation that are within the scope include: 1) fundamental discovery, 2) bench to bedside, 3) clinical trials, 4) translation to clinical guidelines, 5) health policy and usage, and 6) global health. Research covering molecular biology, genetics, pharmacology, imaging and epidemiology is welcome as it contributes to enhancing the field.